General
publicado em 16/04/2013 às 16h49:00
   Dê o seu voto:

Fiocruz partnership between private enterprise and resume domestic production of insulin

The investment forecast is $ 430 million over five years, $ 80 million Fiocruz, and the remainder via BNDES

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Foto: Erasmo Salomão/Ministério da Saúde
Foto: Erasmo Salomão/Ministério da Saúde
Dilma Rousseff, President of the Republic, during the ceremony Alexandre Padilha, Minister of Health
  « Previous
next »  
Dilma Rousseff, President of the Republic, during the ceremony
Alexandre Padilha, Minister of Health

A partnership of public laboratory Oswaldo Cruz Foundation (Fiocruz) with the Brazilian company Biomm, promote the resumption of domestic production of insulin, vital drug to control diabetes. The investment forecast is $ 430 million over the next five years - $ 80 million from the Ministry of Health and Fiocruz, and the remaining funding via the National Bank for Economic and Social Development (BNDES).

The announcement came on the morning of Tuesday (16) in Belo Horizonte, during a ceremony with President of the Republic, Dilma Rousseff, and the Ministers of Health, Alexandre Padilha, and Development, Industry and Foreign Trade (MDIC), Fernando Pimentel . "Can a country like Brazil have weakened industry. We have a great advantage: almost 200 million inhabitants. market We need to turn this into a platform for the world. consumption and investment go hand in hand, said President Dilma.

With the resumption of production of insulin, Brazil back part of the select group of four countries pordutores insulin, along with Ukraine, Denmark and the United States.

Currently, there are about 10 million diabetics in the country. Of these, 1.1 million use insulin provided by the Unified Health System (SUS). In 2012, the average consumption of antidiabetic drugs by the public health system was about 15 million bottles of NPH and about 1.7 million bottles of insulin - 1.2 million bottles of NPH type and 145 000 bottles of regular . The Biomm plans to produce 50% of insulin delivered in SUS.

Source: Isaude.net
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Fiocruz partnership between private enterprise and resume domestic production of insulin
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Fiocruz partnership between private enterprise and resume domestic production of insulin


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
domestic production of insulin    insulin    diabetes Fundação Oswaldo Cruz    Fiocruz    BNDES Ministry of Health    Ministry of Development    Industry and Foreign Trade   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.